Table 3. Prescription of dementia drugs from dementia clinics to patients according to specific diagnosis and gender.
DC 1 (n = 114) | DC 2 (n = 127) | |||||
Prescribed drugs | Prescribed drugs | |||||
AD | AD+VaD | AD | AD+VaD | |||
Male/Female | Male/Female | % | % | Male/Female | Male/Female | |
29% / 46% | 54% / 39% | 44 | Galantamine | 46 | 40% / 49% | 41% / 51% |
21% / 13% | 11% / 27% | 17 | Memantine | 7 | 4% / 4% | 6% / 10% |
50% / 31% | 25% / 15% | 28 | Galantamine and Memantine | 1 | 0% / 0% | 0% / 3% |
0% / 5% | 4% / 18% | 8 | Rivastigmine | 25 | 40% / 22% | 35% / 15% |
0% / 2.5% | 7% / 0% | 3 | Memantine and Rivastigmine | 1 | 0% / 0% | 18% / 3% |
0% / 2.5% | 0% / 0% | 1 | Donepezil | 19 | 16% / 22% | 0% / 18% |
- | - | - | Donepezil and Memantine | 1 | 0% / 2% | |
100/100 | 101/99 | 101 | Total | 100 | 100/99 | 100/100 |